https://principia-scientific.org/new-study-hydroxychloroquine-zinc-greatly-reduces-covid-19-health-risk/

New Study: Hydroxychloroquine + Zinc Greatly Reduces COVID-19 Health Risk

Written by dcwhispers.com

While the main stream media yet again is pushing recycled headlines about a New York “study” of very ill patients who were NOT actually given the combination of hydroxychloroquine and zinc which concluded these near-death patients did no better or worse when given the drug, another study showing a very different result was largely ignored by these same media outlets.

Imagine that.

Check out this headline coming out of New York as well which showed the combination of hydroxychloroquine and zinc slashed the risk of death from the coronavirus by nearly half.


**Drug Combo With Hydroxychloroquine Promising: NYU Study**

NEW YORK – Researchers at NYU’s Grossman School of Medicine found patients given the antimalarial drug hydroxychloroquine along with zinc sulphate and the antibiotic azithromycin were 44 percent less likely to die from the coronavirus.

“Researchers at NYU’s Grossman School of Medicine found patients given the antimalarial drug hydroxychloroquine along with zinc sulphate and the antibiotic azithromycin were 44 percent less likely to die from the coronavirus.

“Certainly we have very limited options as far as what we have seen work for this infection so anything that may work is very exciting,” said Dr. Joseph Rahimian, Infectious Disease Specialist at NYU Langone Health.”

The study looked at the records of 932 COVID-19 patients treated at local hospitals with hydroxychloroquine and azithromycin.

More than 400 of them were also given 100 milligrams of zinc daily.

Researchers Said The Patients Given Zinc Were One And A Half Times More Likely To Recover, Decreasing Their Need For Intensive Care.

If one were to do an online news search right now for similar studies as above you will find story after story on the recycled New York study that showed no benefit from hydroxychloroquine while this other study (also from New York) that indicates the hydroxychloroquine + zinc combination shows remarkable promise, is receiving almost zero media coverage.

This is the same combination that has been touted by physicians all across America and the world as proving highly effective and yet here in the U.S. there are forces both in government and the media who continue to push this success to the side while also pushing yet more fear and panic of the disease.

Did you know that in Italy, one of the nations hardest hit by Covid 19, once doctors started initiating mass use of hydroxychloroquine and zinc, the death rate plummeted from a high of nearly a thousand a day to less than 200? This drug combination protocol has been repeated in other nations like South Korea, France, Bahrain, Turkey, Brazil, etc., with similar rates of success there as well as outlined in this excerpt from an April 21st scientific journal release:

“On March 23, 2020 a physician (Vladimir Zelenko) in Monroe, New York state, published online similar excellent outcomes on treating his patients with shortness of breath and any patient in the high-risk category with HCQ, azithromycin and zinc sulfate for five days in order to prevent hospitalization.

On April 17, 2020 doctors from a health care provider focused on mostly elderly and chronic patients in Brazil confirmed Raoul’s and Zelenko’s findings reporting that out of 636 symptomatic outpatients of the 224 who refused treatment (control group), 12 were hospitalized (5.4%), and of these 12 hospitalized, 5 patients died (41%) [12]. On the other hand, of the 412 outpatients treated with HCQ and azithromycin, only 8 were hospitalized (1.94%), and no deaths were observed. In case of early treatment (<7 days of symptoms) only 1.17% of treated patients needed hospitalization, while the percentage raised to 3.2% for late treatment (>7 days of symptoms). These outcomes were even more remarkable considering that patients in the treatment groups had higher prevalence of comorbidities including diabetes, immunosuppression state and stroke [12]. “

Again, why is there such push-back going on in the United States from the far-left media to dismiss what appears to be the undeniable effectiveness of hydroxychloroquine + zinc in combatting Covid-19?

Something very weird is going on here and people have been dying by the thousands because of it.

Good news, possibly life-saving news, is being pushed aside while bad news, not matter how flawed or biased, is put front and center in an effort to convince tens of millions that there is currently no real treatment options for the coronavirus even as so much data out there appears to say that is simply not so.

Read more at www.ny1.com

__________________________

**Comment**

For the reason why the media and “authorities” badmouth HCQ:   https://principia-scientific.org/a-tale-of-2-drugs-deep-state-chose-money-power-over-lives/

Excerpt:

Approximately $70 million in U.S. taxpayer funding began Gilead’s partnership with the U.S. Army, Centers for Disease Control and Prevention (CDC) and National Institutes of Health (NIH) to develop remdesivir. Initially for treating Ebola, it failed to show benefit and was shelved. If remdesivir is used to treat COVID-19, Gilead shareholders, not the taxpayers, will profit.

HCQ directly competes with the favored profitable treatment of remdesivir.

In fact the article states that 9 of the 19 experts on the COVID-19 treatment panel have financial interests in Gilead Science.  See the problem?

Early results of the first clinical trial of remdesivir against placebo in coronavirus showed modest benefits, according to The New York Times. Surviving patients given remdesivir were discharged four days sooner than patients given placebo, though no criteria were given for determining improvement. Death rates were not significantly different. About 25% of patients receiving remdesivir had potentially severe side effects, including multiple organ dysfunction, septic shock, acute kidney injury and low blood pressure. Another 23% showed evidence on lab tests of liver damage.

Gilead’s own press release revealed the side effect of acute respiratory failure in 6% of patients in the remdesivir five-day treatment group, and 10.7% of patients in the 10-day treatment group, clearly ominous findings with a drug designed to treat respiratory failure caused by COVID-19.

Dr. Steven Nissen, a Cleveland Clinic cardiologist who has conducted dozens of clinical trials, explained to The New York Times:

The disclosure of trial results in a political setting, before peer review or publication, is very unusual. Scientists will need to see figures on harms associated with the drug in order to assess its benefits. … This is too important to be handled in such a sloppy fashion.”

Going back to 1997, Donald Rumsfeld chaired the Board of Directors at Gilead and after 2001 he held share packages valued at $5-25 Million. Gilead originally developed Tamiflu. George P Shultz, US Secretary of State also was on the board. He sold stocks at a value of more than $7 million. CA governor’s Pete Wilson’s wife also sat on the board.

‘I don’t know of any biotech company that’s’ so politically well-connected [as Gilead],‘ Andrew McDonald, of the analyst firm Think Equity Partners, told Fortune.” (Source: “Virus Mania, How the Medical Industry Continually Invents Epidemics Making Billion Dollar Profits At Our Expense”)

Shunning competing tests and treatments if what the CDC does:  https://madisonarealymesupportgroup.com/2020/04/26/cdc-playbook-learning-from-lyme/

These fraudsters need to go to jail.  Contact your representatives and senators:  https://madisonarealymesupportgroup.com/2020/05/20/cdc-crimes-possible-sherman-provisions-clayton-acts-violated/